Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

SHE:300119 Revenue

Tianjin Ringpu Bio-Technology had revenue of 894.33M CNY in the quarter ending June 30, 2026, with 0.94% growth. This brings the company's revenue in the last twelve months to 3.41B, up 1.50% year-over-year. In the year 2025, Tianjin Ringpu Bio-Technology had annual revenue of 3.40B with 10.70% growth.

• Revenue (ttm): 3.41B
• Revenue Growth: +1.50%
• P/S Ratio: 2.23
• Revenue / Employee: 1.22M
• Employees: 2,803
• Market Cap: 7.61B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.40B	328.53M	10.70%
Dec 31, 2024	3.07B	360.83M	13.32%
Dec 31, 2023	2.71B	624.85M	29.98%
Jan 1, 2023	2.08B	77.11M	3.84%
Jan 1, 2022	2.01B	6.73M	0.34%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 1, 2026

Data Sources Report a data error